According to the International Ki-67 in Breast Cancer Working Group (IKWG) Consensus Meeting Guideline (2019) [28], Ki-67 analysis should only be used to guide clinical decisions with 5% or less or 30% or more. Here, MKI67 is linked to breast cancer.